These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15032638)

  • 1. Modulation of innate immune responses in the treatment of sepsis and pneumonia.
    Schultz MJ; van der Poll T
    Curr Drug Targets Inflamm Allergy; 2004 Mar; 3(1):11-7. PubMed ID: 15032638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumonia models and innate immunity to respiratory bacterial pathogens.
    Knapp S; Schultz MJ; van der Poll T
    Shock; 2005 Dec; 24 Suppl 1():12-8. PubMed ID: 16374367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal and human models for sepsis.
    Schultz MJ; van der Poll T
    Ann Med; 2002; 34(7-8):573-81. PubMed ID: 12553497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Immune System Regulation in Sepsis: From Innate to Adaptive.
    Qiu Y; Tu GW; Ju MJ; Yang C; Luo Z
    Curr Protein Pept Sci; 2019; 20(8):799-816. PubMed ID: 30843486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetics of severe respiratory infections: models for the development of new therapeutic strategies.
    Bocchino M; Marruchella A; Saltini C
    Respiration; 2005; 72(5):449-57. PubMed ID: 16210881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary defense mechanisms against pneumonia and sepsis.
    Tsai KS; Grayson MH
    Curr Opin Pulm Med; 2008 May; 14(3):260-5. PubMed ID: 18427251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Dendritic Cell Responses to Sepsis-Induced Immunosuppression and to Susceptibility to Secondary Pneumonia.
    Bouras M; Asehnoune K; Roquilly A
    Front Immunol; 2018; 9():2590. PubMed ID: 30483258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of host defense peptides of the innate immune response in sepsis.
    Hirsch T; Metzig M; Niederbichler A; Steinau HU; Eriksson E; Steinstraesser L
    Shock; 2008 Aug; 30(2):117-26. PubMed ID: 18091568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor and innate immune responses to bacterial infections.
    Froidevaux C; Roger T; Martin C; Glauser MP; Calandra T
    Crit Care Med; 2001 Jul; 29(7 Suppl):S13-5. PubMed ID: 11445727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?
    Boomer JS; Green JM; Hotchkiss RS
    Virulence; 2014 Jan; 5(1):45-56. PubMed ID: 24067565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Activation in Sepsis.
    Conway-Morris A; Wilson J; Shankar-Hari M
    Crit Care Clin; 2018 Jan; 34(1):29-42. PubMed ID: 29149940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view.
    Schulte W; Bernhagen J; Bucala R
    Mediators Inflamm; 2013; 2013():165974. PubMed ID: 23853427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas immune globulin therapy improves survival in experimental Pseudomonas aeruginosa bacteremic pneumonia.
    Collins MS; Edwards A; Roby RE; Mehton NS; Ladehoff D
    Antibiot Chemother (1971); 1989; 42():184-92. PubMed ID: 2596836
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.
    Yang L; Cai C; Feng Q; Shi Y; Zuo Q; Yang H; Jing H; Wei C; Zhuang Y; Zou Q; Zeng H
    Sci Rep; 2016 Feb; 6():20929. PubMed ID: 26865417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunomodulating strategies in the treatment of sepsis].
    Schultz MJ; van der Poll T
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2530-3. PubMed ID: 12532664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inflammatory caspases: guardians against infections and sepsis.
    Scott AM; Saleh M
    Cell Death Differ; 2007 Jan; 14(1):23-31. PubMed ID: 16977333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.
    Shindo Y; Fuchs AG; Davis CG; Eitas T; Unsinger J; Burnham CD; Green JM; Morre M; Bochicchio GV; Hotchkiss RS
    J Leukoc Biol; 2017 Feb; 101(2):543-554. PubMed ID: 27630218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine modulation in sepsis and septic shock.
    Zanotti S; Kumar A; Kumar A
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1061-75. PubMed ID: 12150702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the 34C>T Variant of the AMPD1 Gene on Immune Function, Multi-Organ Dysfunction, and Mortality in Sepsis Patients.
    Ramakers BP; Giamarellos-Bourboulis EJ; Tasioudis C; Coenen MJ; Kox M; Vermeulen SH; Groothuismink JM; van der Hoeven JG; Routsi C; Savva A; Prekates A; Diamantea F; Sinapidis D; Smits P; Toutouzas K; Riksen NP; Pickkers P;
    Shock; 2015 Dec; 44(6):542-7. PubMed ID: 26529652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.
    Hotchkiss RS; Monneret G; Payen D
    Nat Rev Immunol; 2013 Dec; 13(12):862-74. PubMed ID: 24232462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.